These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33758900)
1. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study. Wiens KE; Mawien PN; Rumunu J; Slater D; Jones FK; Moheed S; Caflish A; Bior BK; Jacob IA; Lako RLL; Guyo AG; Olu OO; Maleghemi S; Baguma A; Hassen JJ; Baya SK; Deng L; Lessler J; Demby MN; Sanchez V; Mills R; Fraser C; Charles RC; Harris JB; Azman AS; Wamala JF medRxiv; 2021 Mar; ():. PubMed ID: 33758900 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020 Wiens KE; Mawien PN; Rumunu J; Slater D; Jones FK; Moheed S; Caflisch A; Bior BK; Jacob IA; Lako RL; Guyo AG; Olu OO; Maleghemi S; Baguma A; Hassen JJ; Baya SK; Deng L; Lessler J; Demby MN; Sanchez V; Mills R; Fraser C; Charles RC; Harris JB; Azman AS; Wamala JF Emerg Infect Dis; 2021 Jun; 27(6):1598-1606. PubMed ID: 34013872 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic. Abdella S; Riou S; Tessema M; Assefa A; Seifu A; Blachman A; Abera A; Moreno N; Irarrazaval F; Tollera G; Browning D; Tasew G EClinicalMedicine; 2021 May; 35():100880. PubMed ID: 34124630 [TBL] [Abstract][Full Text] [Related]
4. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy. Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey. Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464 [TBL] [Abstract][Full Text] [Related]
6. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland. Brown AC; Koshute PT; Cowley HP; Robinette MS; Gravelyn SR; Patel SV; Ju EY; Frommer CT; Zambidis AE; Schneider EJ; Zhao MY; Mugo BK; Clarke W; Kruczynski K; Pisanic N; Heaney CD; Colella TA Microbiol Spectr; 2023 Aug; 11(4):e0276522. PubMed ID: 37289070 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 seroprevalence in people living with HIV in South Sudan. Chun HM; Lodiongo DK; Milligan K; Lesuk GJ; Patel D; Shiraishi RW; Martin D; Simon AK; Dirlikov E; Patel HK; Ellenberger D; Worku HA; Duong YT; Ekong RO; Katoro JS; Hussen SA; Lokore ML; Wani G; Bunga S IJID Reg; 2024 Sep; 12():100421. PubMed ID: 39281194 [TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey. Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144 [TBL] [Abstract][Full Text] [Related]
11. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey. Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591 [TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States. Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M medRxiv; 2020 Oct; ():. PubMed ID: 33140066 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling. Lorenz E; Souares A; Amuasi J; Loag W; Deschermeier C; Fusco D; Benke D; A Rakotoarivelo R; Rasamoelina MT; Rakotozandrindrainy R; Sie A; Afum-Adjei Awuah A; May J; Eibach D; Struck N BMJ Open; 2021 Dec; 11(12):e056853. PubMed ID: 34921091 [TBL] [Abstract][Full Text] [Related]
17. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA Front Immunol; 2021; 12():693462. PubMed ID: 34691016 [TBL] [Abstract][Full Text] [Related]
18. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic. Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689 [TBL] [Abstract][Full Text] [Related]
19. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys. Angulo FJ; Finelli L; Swerdlow DL JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]